Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome

NCT02545413 ·Status: WITHDRAWN ·Phase: PHASE3

Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D

NCT01638208 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

NCT00699166 ·Status: COMPLETED ·Phase: PHASE2

Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

NCT07238790 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption

NCT03270085 ·Status: COMPLETED ·Phase: PHASE2

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

NCT02239926 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

NCT06153420 ·Status: TERMINATED ·Phase: PHASE2

A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)

NCT01076699 ·Status: SUSPENDED ·Phase: PHASE2

A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients

NCT05900752 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D

NCT06247046 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of a Probiotic Supplement in IBS-D

NCT05754177 ·Status: COMPLETED ·Phase: NA

Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)

NCT00194922 ·Status: COMPLETED ·Phase: PHASE2

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

NCT00230581 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

NCT03977155 ·Status: COMPLETED ·Phase: PHASE2

Probiotics and Irritable Bowel Syndrome

NCT04572932 ·Status: COMPLETED ·Phase: NA

The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)

NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg

NCT01358708 ·Status: TERMINATED ·Phase: PHASE3

The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients

NCT02254629 ·Status: COMPLETED ·Phase: PHASE1

Vetal Laban Intervention Trial Assessing Bowel Symptoms

NCT01887483 ·Status: TERMINATED ·Phase: PHASE4

Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea

NCT01667627 ·Status: COMPLETED ·Phase: PHASE4

B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis

NCT06612411 ·Status: RECRUITING ·Phase: EARLY_PHASE1

SH-DS01 on Fecal Metagenomic Stability

NCT04598295 ·Status: COMPLETED ·Phase: PHASE2

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

NCT03931785 ·Status: COMPLETED ·Phase: PHASE2

A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome

NCT01736423 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT05509725 ·Status: RECRUITING ·Phase: PHASE4